Clinical Trials Arena April 4, 2025
DCTs were readily adopted during the pandemic, with many believing they were more sustainable, but experts are now questioning this.
During the pandemic, sponsors and biotechs started running decentralised clinical trials (DCTs) to keep research going when patients had less face-to-face access to clinicians, with the added benefit that they could be more sustainable.
At the time, it was thought that DCTs would be the future, however, five years on, while they have not disappeared entirely, sponsors seem to be adopting more hybrid clinical trial models.
GlobalData’s Pharmaceutical Intelligence Center shows a slight uptick in 2024 for DCT adoption compared to 2023, but the numbers remain low compared to 2021. You can follow the Clinical Trials Arena’s DCT Adoption Tracker...
Today's Sponsors
Today's Sponsor